Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 18, 2026, 15:18Ossama Mansour: First Resource Stratified Guidelines for Acute Ischemic Stroke in the MENA Region
-
Mar 18, 2026, 15:16Ifeanyichukwu Ifechidere: Interpreting Abnormal Coagulation Results Through Two Practical Cases
-
Mar 18, 2026, 15:14Heghine Khachatryan: Platelets and Cancer Metastasis – More Than Just Hemostasis
-
Mar 18, 2026, 15:13Bhavna Gupta: When Not to Use AI in Clinical Practice
-
Mar 18, 2026, 12:53Maxime Dely: Why I Took My Toddler to a Blood Donation Session
-
Mar 18, 2026, 12:22Anita Brikman: Advancing Plasma-Derived Therapies in India Through Global Collaboration
-
Mar 18, 2026, 12:17Ben Samelson-Jones: Long-Term Safety and Efficacy of AAV Gene Therapy Using FIX-Padua in Hemophilia B
-
Mar 18, 2026, 12:14Sakditad Saowapa: Optimizing Sexual Activity and Minimizing Infection Risk in Patients with Neutropenia
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management